Giulia Romagnoli
Overview
Explore the profile of Giulia Romagnoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Offi M, Gabriele L, Romagnoli G, Lauretti L, Pallini R, DAlessandris Q
Neuro Oncol
. 2024 Jun;
26(8):1538-1539.
PMID: 38885219
No abstract available.
2.
Romagnoli G, DAlessandris Q, Capone I, Tavilla A, Canini I, Lapenta C, et al.
Immunology
. 2023 Oct;
171(2):198-211.
PMID: 37884280
Glioblastoma, isocitrate dehydrogenase-wildtype (GB), is the most common and aggressive primary brain malignancy with poor outcome. Immune checkpoint inhibitors (ICIs) have been tested in GB and, despite disappointing results, the...
3.
Esposito L, Romagnoli G
Heliyon
. 2023 Jul;
9(7):e17406.
PMID: 37519681
In recent years, the international community has been strongly committed to promoting energy transition due to the various challenges presented by the global energy market. In this context, renewable sources...
4.
Fragale A, Stellacci E, Romagnoli G, Licursi V, Parlato S, Canini I, et al.
Int J Cancer
. 2023 Jun;
153(5):1080-1095.
PMID: 37293858
BRAF mutations are the most common oncogenic alterations in melanoma cells, supporting proliferation, invasion, metastasis and immune evasion. In patients, these aberrantly activated cellular pathways are inhibited by BRAFi whose...
5.
Governa P, Romagnoli G, Albanese P, Rossi F, Manetti F, Biagi M
J Enzyme Inhib Med Chem
. 2023 Mar;
38(1):2183810.
PMID: 36916299
(HP) is among the most common pathogens causing infection in humans worldwide. Oxidative stress and gastric inflammation are involved in the progression of HP-related gastric diseases, and they can be...
6.
Gabriele L, Fragale A, Romagnoli G, Parlato S, Lapenta C, Santini S, et al.
Cytokine Growth Factor Rev
. 2020 Oct;
58:66-74.
PMID: 33071044
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, induces severe pneumonia mainly in elderly males. Epidemiological data clearly indicate sex-based...
7.
DAlterio C, Buoncervello M, Ierano C, Napolitano M, Portella L, Rea G, et al.
J Exp Clin Cancer Res
. 2019 Oct;
38(1):432.
PMID: 31661001
Background: Inefficient T-cell access to the tumor microenvironment (TME) is among the causes of tumor immune-resistance. Previous evidence demonstrated that targeting CXCR4 improves anti-PD-1/PD-L1 efficacy reshaping TME. To evaluate the...
8.
Parlato S, Chiacchio T, Salerno D, Petrone L, Castiello L, Romagnoli G, et al.
PLoS One
. 2018 Jan;
13(1):e0189477.
PMID: 29320502
Individuals exposed to Mycobacterium tuberculosis (Mtb) may be infected and remain for the entire life in this condition defined as latent tuberculosis infection (LTBI) or develop active tuberculosis (TB). Among...
9.
Fragale A, Romagnoli G, Licursi V, Buoncervello M, Del Vecchio G, Giuliani C, et al.
Cancer Immunol Res
. 2017 Jun;
5(7):604-616.
PMID: 28615266
Colorectal cancer results from the progressive accumulation of genetic and epigenetic alterations. IFN signaling defects play an important role in the carcinogenesis process, in which the inability of IFN transcription...
10.
Parlato S, De Ninno A, Molfetta R, Toschi E, Salerno D, Mencattini A, et al.
Sci Rep
. 2017 Apr;
7(1):1093.
PMID: 28439087
Immunotherapy efficacy relies on the crosstalk within the tumor microenvironment between cancer and dendritic cells (DCs) resulting in the induction of a potent and effective antitumor response. DCs have the...